SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (184)5/23/2000 11:56:00 AM
From: scaram(o)uche  Read Replies (1) of 1833
 
haven't read it yet.... if others can dig in, would appreciate it......

This Form 10-K/A is being filed to amend two items of the annual report on
Form 10-K of OSI Pharmaceuticals, Inc. for the fiscal year ended September 30,
1999, which was filed with the Securities and Exchange Commission on December
29, 1999 and amended on January 25, 2000. Item 7, Management's Discussion and
Analysis of Financial Condition and Results of Operations, Liquidity and Capital
Resources, is amended to add additional information with respect to the
acquisition by the Registrant of certain assets from Cadus Pharmaceutical
Corporation; and Item 8, Consolidated Financial Statements and Supplementary
Data, Notes to Consolidated Financial Statements, footnote number 1(h) is
amended to provide additional disclosure regarding accounting for certain of the
Registrant's investments and footnote number 3(a) is amended to revise the
disclosure regarding the Cadus acquisition.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext